Slava Ziegler

Title: Slava Ziegler: Innovator in Glucose Transport Inhibition

Introduction

Slava Ziegler is a notable inventor based in Dortmund, Germany. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that inhibit glucose transporters.

Latest Patents

Ziegler holds a patent for "Inhibitors of glucose transporters (GLUTs)." This invention relates to 2,6-methanobenzo[g][1]oxacin-4-one compounds and their analogs, which serve as selective inhibitors of glucose transporters 1 and 3 (GLUTs 1 and 3). The patent outlines methods for preparing these compounds and their use as pharmaceutically active agents. These agents are particularly relevant for the prophylaxis and treatment of various metabolic, immunological, and autoimmune diseases, as well as inflammation, graft versus host disease, cancer, and metastasis. Additionally, the invention includes pharmaceutical compositions comprising these compounds.

Career Highlights

Throughout her career, Slava Ziegler has worked with prominent organizations such as Lead Discovery Center GmbH and the Max Planck Society for the Advancement of Science. Her work has focused on innovative approaches to drug development and the exploration of new therapeutic avenues.

Collaborations

Ziegler has collaborated with esteemed colleagues, including Herbert Waldmann and Gunther Zischinsky. These partnerships have contributed to her research and the advancement of her inventions.

Conclusion

Slava Ziegler's work in the field of glucose transporter inhibition showcases her innovative spirit and dedication to addressing critical health challenges. Her contributions continue to impact the pharmaceutical landscape significantly.